Intercept 304 Study 17+
Snapiot Inc
Designed for iPad
-
- Free
Screenshots
Description
This telemedicine app is intended to be used by patients enrolled in Intercept's 304 study. The purpose of this app is to connect patients and clinician's for the purpose of Intercept's study. Patients will use this app to schedule and conduct telemedicine calls.
This app is intended for users who are age 18 and over.
What’s New
Version 3.0
Telemedicine 3 party call feature added
App Privacy
The developer, Snapiot Inc, has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer’s privacy policy.
No Details Provided
The developer will be required to provide privacy details when they submit their next app update.
Information
- Seller
- Snapiot
- Size
- 62 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 10.0 or later.
- iPad
- Requires iPadOS 10.0 or later.
- iPod touch
- Requires iOS 10.0 or later.
- Mac
- Requires macOS 11.0 or later and a Mac with Apple M1 chip.
- Languages
-
English
- Age Rating
- 17+ Frequent/Intense Medical/Treatment Information
- Copyright
- © 2020 Intercept Pharmaceuticals, Inc.
- Price
- Free